Ambu AS 2025 AR2
The report highlights Ambu's transition to its next-era ZOOM AHEAD strategy, aiming for global endoscopy leadership. During the 2024/25 fiscal year, the company achieved 13.1% organic revenue growth and reached an EBIT margin before special items of 13.0%. In sustainability, Ambu launched the Ambu® Recircle Program, a pioneering endoscope recycling initiative, and expanded its use of bioplastics in endoscope handles. Additionally, the company reduced its market-based Scope 1 and 2 greenhouse gas emissions by 43% from its 2020/21 baseline and sourced 37% of its total energy from renewable sources.
Company: Ambu AS
Sector: Health Care
Country: Denmark
Year: 2025
Type: AR2
Pages: 196
Ambu AS
Annual Report
The report highlights Ambu's transition to its next-era ZOOM AHEAD strategy, aiming for global endoscopy leadership. During the 2024/25 fiscal year, the company achieved 13.1% organic revenue growth and reached an EBIT margin before special items of 13.0%. In sustainability, Ambu launched the Ambu® Recircle Program, a pioneering endoscope recycling initiative, and expanded its use of bioplastics in endoscope handles. Additionally, the company reduced its market-based Scope 1 and 2 greenhouse gas emissions by 43% from its 2020/21 baseline and sourced 37% of its total energy from renewable sources.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Oct 1, 2024 - Sep 30, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees